A WANDER SA DR has a total of 15 patent applications. Its first patent ever was published in 1960. It filed its patents most often in United States, Spain and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are DONAU PHARMAZIE G M B H, HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY CO LTD and YANG ZIJIAO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Spain | 2 | |
#3 | Australia | 1 | |
#4 | Belgium | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Foods and drinks | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Cocoa and sweets | |
#4 | Spraying devices | |
#5 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Hunziker Fritz | 4 |
#2 | Schmutz Jean | 4 |
#3 | Kunzle Franz Martin | 3 |
#4 | Schindler Othmar | 2 |
#5 | Picard Claude W | 2 |
#6 | Bream John Bernard | 2 |
#7 | Picard Claude Wolfgang | 1 |
#8 | Martin Franz | 1 |
#9 | Bream John B | 1 |
#10 | Wyss Edmond G | 1 |
Publication | Filing date | Title |
---|---|---|
BE773789Q | 5-Dibenzo-/b:c/-/1:4/-diazepineamidines (wherein R is S, SO, or -NR1-, where R1 is H, a dissociatable group such as acyl, alkyl or akenyl with 1-5C atoms or a | |
US3546226A | 11-basic-substituted dibenzoxazepines | |
US3454561A | 5-basic substituted 5,6-dihydro-6-oxomorphanthridines | |
US3622596A | Carbanilide compounds | |
US3478056A | 11-aminoalkylated dibenz(b,f) - 1,4-oxazepines and dibenzo-(b,f)-1,4-thiazepines | |
US3459850A | Sustained-release tablets,a process and a composition for their preparation | |
ES261194A1 | Procedure for the preparation of heterocyclic compounds replaced with a base (Machine-translation by Google Translate, not legally binding) |